Zobrazeno 1 - 10
of 18
pro vyhledávání: '"D C, Perlman"'
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 4(1)
To evaluate the prevalence and predictors of tuberculin skin test (TST) reactionsor =10 mm among active injection drug users (IDUs) at a syringe exchange program in New York City.From August 1995 to January 1996, participants were offered TB screenin
Publikováno v:
Seminars in respiratory infections. 14(4)
Tuberculosis (TB) is the major opportunistic infection of human immunodeficiency virus (HIV)-infected persons worldwide. Human immunodeficiency virus infection is the most potent known risk factor for reactivation of latent Mycobacterium tuberculosis
Autor:
N, Salomon, D C, Perlman
Publikováno v:
Seminars in respiratory infections. 14(4)
Cytomegalovirus (CMV) pneumonia is a major cause of morbidity and mortality in allogeneic bone marrow transplant and lung transplant recipients. However, its role as a cause of lung disease in patients with the human immunodeficiency virus (HIV) is c
Autor:
E E, Telzak, K D, Chirgwin, E T, Nelson, J P, Matts, K A, Sepkowitz, C A, Benson, D C, Perlman, W M, El-Sadr
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(4)
Mortality associated with human immunodeficiency virus (HIV) related multidrug-resistant tuberculosis (MDR-TB) is reduced with effective early therapy. Identifying predictors of, and effective regimens for, MDR-TB is critical.A multicenter prospectiv
Publikováno v:
Journal of substance abuse treatment. 16(3)
Tuberculosis is an important health issue among drug users. We sought to evaluate active drug users' (DUs) knowledge of tuberculosis (TB) and to assess the relationship between TB knowledge and attitudes and tuberculin skin test (TST) return rates at
Autor:
L A, Green, F S, Rhame, R W, Price, D C, Perlman, L G, Capps, J H, Sampson, L R, Deyton, S M, Schnittman, E J, Fisher, G E, Bartsch, E A, Krum, J D, Neaton
Publikováno v:
AIDS (London, England). 12(15)
To describe the methods and results of a standardized system for clinical endpoint determination for defining and reviewing endpoints in clinical trials for HIV-infected individuals.A system was developed utilizing standard definitions for the 24 dia
Autor:
W M, el-Sadr, D C, Perlman, J P, Matts, E T, Nelson, D L, Cohn, N, Salomon, M, Olibrice, F, Medard, K D, Chirgwin, D, Mildvan, B E, Jones, E E, Telzak, O, Klein, L, Heifets, R, Hafner
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 26(5)
This study examined whether adding levofloxacin to a standard four-drug regimen improved the 8-week culture response and compared effectiveness of 9 versus 6 months of intermittent therapy for human immunodeficiency virus-related pansusceptible pulmo
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 1(5)
Directly observed therapy (DOT) program for tuberculosis (TB) at a New York City hospital.To describe a specific TB DOT program model utilizing active prospective identification of inpatients, and identify factors associated with patient acceptance o
Publikováno v:
JAMA. 278(21)
Autor:
D C, Perlman, W M, El Sadr, L B, Heifets, E T, Nelson, J P, Matts, K, Chirgwin, N, Salomon, E E, Telzak, O, Klein, B N, Kreiswirth, J M, Musser, R, Hafner
Publikováno v:
AIDS (London, England). 11(12)
To characterize the susceptibility to levofloxacin of clinical isolates of Mycobacterium tuberculosis (MTB) obtained from patients with HIV-related tuberculosis and to characterize the molecular genetics of levofloxacin resistance.Isolates from cultu